Brooks Laboratories quarterly results and financials

Brooks Laboratories (BROOKS)₹65.75−0.32%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), Brooks Laboratories reported sales of ₹23.05 Cr, down 10.0% from Jun 2025, and net profit of −₹1.78 Cr, down 118.6% year on year. For the year to Mar 2026, sales were ₹86.25 Cr and net profit ₹24.96 Cr.

Sales (Jun 2026): ₹23.05 Cr
Net profit (Jun 2026): −₹1.78 Cr
Sales (FY Mar 2026): ₹86.25 Cr
Net profit (FY Mar 2026): ₹24.96 Cr
EPS (Jun 2026): ₹−0.60
Borrowings (Mar 2026): ₹9.01 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

Brooks Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

Brooks Laboratories Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	24.41	21.83	17.77	17.99	20.85	20.60	23.40	25.61	23.52	16.63	20.27	23.05
Expenses	25.47	25.17	27.29	19.87	24.24	22.06	24.63	22.43	20.97	15.85	19.55	24.32
Operating Profit	−1.11	−3.38	−9.56	−1.93	−3.42	−1.51	−1.27	3.14	2.53	0.74	0.69	−1.35
OPM %	−4.5%	−15.5%	−53.7%	−10.7%	−16.4%	−7.3%	−5.4%	12.3%	10.8%	4.4%	3.4%	−5.8%
Other Income	0.08	0.15	0.64	0.06	0.19	0.02	0.61	7.14	6.11	5.31	1.34	0.17
Interest	0.20	0.22	0.28	0.17	0.33	0.29	0.27	0.31	0.29	0.17	0.10	0.22
Depreciation	0.45	0.44	0.47	0.41	0.44	0.39	0.40	0.40	0.40	0.40	0.42	0.43
Profit before tax	−1.63	−3.84	−9.62	−2.40	−3.95	−2.12	−1.28	9.58	7.97	5.49	1.52	−1.80
Tax %	0.0%	0.8%	0.0%	0.0%	0.0%	0.0%	14.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net Profit	−1.63	−3.87	−9.60	−2.40	−3.95	−2.12	−1.45	9.56	7.96	5.49	1.51	−1.78
EPS (Rs)	−0.61	−1.47	−3.65	−0.91	−1.50	−0.80	−0.49	3.24	2.70	1.86	0.51	−0.60

Brooks Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Brooks Laboratories Profit and loss
	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	77.29	91.29	63.23	79.22	83.29	86.25	83.47
Expenses	77.14	105	93.13	97.13	91.18	79.06	80.69
Operating Profit	1.01	−14.02	−30.06	−18.05	−8.02	7.01	2.61
OPM %	0.7%	−16.0%	−47.0%	−22.0%	−10.0%	8.0%	3.1%
Other Income	0.99	0.99	0.99	0.99	0.99	19.97	12.93
Interest	3.01	3.01	2.01	1.01	1.01	1.01	0.78
Depreciation	7.03	7.03	7.02	2.01	2.01	2.01	1.65
Profit before tax	−8.99	−23.97	−38.01	−20.01	−9.99	24.98	13.18
Tax %	115.0%	−19.0%	−19.0%	0.0%	2.0%	0.0%	—
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Profit	−18.95	−18.98	−30.96	−19.97	−9.99	24.96	13.18
EPS (Rs)	−7.38	−4.30	−7.96	−7.44	−3.37	8.32	4.47
Dividend payout %	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—

Brooks Laboratories balance sheet

₹ crore, at each year end.

Brooks Laboratories Balance sheet
	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	25.07	25.05	25.06	26.07	29.09	29.11
Reserves	53.76	62.76	48.94	38.94	68.97	93.00
Borrowings	31.01	24.98	7.00	6.00	8.02	9.01
Other Liabilities	52.19	83.34	29.14	19.09	18.09	17.08
Total Liabilities	162	196	110	90.10	124	148
Fixed Assets	108	110	14.97	13.97	13.98	14.97
CWIP	0.99	14.99	0.00	0.00	0.00	0.99
Investments	0.00	0.00	64.06	43.01	74.04	92.10
Other Assets	54.18	71.32	31.11	34.12	36.15	40.14
Inventories	23.56	27.46	11.28	9.59	9.18	10.99
Trade receivables	13.71	17.65	12.74	16.31	19.98	16.10
Cash & equivalents	1.69	3.80	1.07	0.68	1.24	7.53
Total Assets	162	196	110	90.10	124	148

Brooks Laboratories cash flow

₹ crore, for each year.

Brooks Laboratories Cash flow
	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	4.01	−37.02	−14.01	−9.99	3.01	8.99
Cash from investing activity	−4.99	−24.96	0.00	0.00	−44.96	−2.99
Cash from financing activity	1.01	64.07	11.01	10.02	42.06	0.00
Net cash flow	0.00	2.01	−3.01	0.00	0.00	7.02
Capex	5.59	27.53	0.46	0.43	0.91	3.50
Free cash flow	−0.99	−61.83	−14.96	−9.97	1.99	5.99
CFO / OP %	1,519.1%	261.1%	48.1%	56.0%	−26.0%	131.1%

Brooks Laboratories ratios

Working-capital days and returns, by year.

Brooks Laboratories Ratios
	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	65	71	74	75	88	69
Inventory days	177	156	79	59	60	76
Days payable	234	160	166	98	91	81
Cash conversion cycle	9	68	−12	38	59	66
Working capital days	−85	34	−37	34	43	34
ROCE %	—	−15.9%	−29.9%	−24.9%	−9.9%	21.1%

Brooks Laboratories: frequently asked questions

What are the latest quarterly results of Brooks Laboratories?

For the Jun 2026 quarter, Brooks Laboratories reported sales of ₹23.05 Cr, down 10.0% year on year and net profit of −₹1.78 Cr, down 118.6% year on year. The operating margin was −5.8%.

What is the annual revenue of Brooks Laboratories?

Brooks Laboratories' sales for the year to Mar 2026 were ₹86.25 Cr; over the last twelve months they were ₹83.47 Cr.

What is the net profit of Brooks Laboratories?

Net profit for the year to Mar 2026 was ₹24.96 Cr, and ₹13.18 Cr over the last twelve months. Earnings per share over the same trailing period were ₹4.47.

How much debt does Brooks Laboratories have?

Brooks Laboratories reported borrowings of ₹9.01 Cr at Mar 2026, against cash and equivalents of ₹7.53 Cr.

What is the free cash flow of Brooks Laboratories?

Cash from operations was ₹8.99 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹5.99 Cr.

Loading…